Atlas Trials

Unresectable Colorectal Carcinoma

14 clinical trials · Condition

Sort:Newest firstOldest first

◉ Watch Unresectable Colorectal Carcinoma

RecordFirmDate
Rintatolimod and Pembrolizumab for the Treatment of Refractory Metastatic or Unresectable Colorectal Cancer (NCT04119830)Roswell Park Cancer Institute2022-02-01
Testing the Combination of Two Anti-cancer Drugs, DS-8201a and AZD6738, for The Treatment of Advanced Solid Tumors Expressing the HER2 Protein or Gene, The DASH Trial (NCT04704661)National Cancer Institute (NCI)2021-08-09
LY3214996 and Cetuximab Alone or in Combination With Abemaciclib for the Treatment of Unresectable or Metastatic Colorectal Cancer (NCT04616183)M.D. Anderson Cancer Center2020-12-02
Pemigatinib for the Treatment of Metastatic or Unresectable Colorectal Cancer Harboring FGFR Alterations (NCT04096417)Academic and Community Cancer Research United2020-08-31
Panitumumab, Regorafenib, or TAS-102, in Treating Patients With Metastatic and/or Unresectable RAS Wild-Type Colorectal Cancer (NCT03992456)Academic and Community Cancer Research United2020-04-24
TAS-102, Irinotecan, and Bevacizumab for the Treatment of Pre-treated Metastatic or Unresectable Colorectal Cancer, the TABAsCO Study (NCT04109924)Roswell Park Cancer Institute2019-12-27
M6620 and Irinotecan Hydrochloride in Treating Patients With Solid Tumors That Are Metastatic or Cannot Be Removed by Surgery (NCT02595931)National Cancer Institute (NCI)2016-07-22

Track Unresectable Colorectal Carcinoma automatically

Every clearance here is in the API, with alerts when new ones post.